RMEI Medical Education

What RMEI Medical Education does

RMEI Medical Education, LLC is a privately held, jointly accredited continuing medical education (CME) provider founded in 2005 and headquartered in Voorhees, New Jersey. The company designs and delivers accredited continuing education activities for physicians, pharmacists, nurses, social workers, and other healthcare professionals across ten specialty therapeutic areas including gastroenterology, hematology/oncology, allergy and immunology, infectious disease, transplant medicine, neuroscience, ophthalmology, dermatology, psychiatry, and pulmonology. Its core technology stack consists of a web-based CE delivery platform and the IBD Clinical Decision Support Tool (CDST), a predictive analytics application co-developed with ArcheMedX and the US IBD Health Outcomes Consortium that forecasts biologic treatment remission for individual IBD patients and was endorsed by the American Gastroenterological Association in 2021.

The company's educational programming is built around 13 or more trademarked proprietary formats (Clinical Convergence, Clinical Consults, Care Team Forum, Clinical Forum, Clinical Olympics, Clinical Sprints, and others) that combine narrative medicine principles, patient voices, and gamified learning. Activities are distributed through the RMEI website, third-party CE aggregators (freecme.com, RealCME, checkbox.com), live in-person and virtual events, and a network of over 100 accredited partner providers including academic medical centers.

RMEI's revenue model is funded entirely by independent educational grants from pharmaceutical companies including Takeda Pharmaceuticals, Genentech, Insmed, and CSL Behring. All CE activities are provided free of charge to healthcare professionals, with credit issued upon post-test and evaluation completion. The company also operates a Join Our Network clinician membership program and develops patient education resources in partnership with non-profit organizations such as The Leukemia & Lymphoma Society, Crohn's & Colitis Foundation, and The Lustgarten Foundation, as well as the CDC. Joint Accreditation from ACCME, ACPE, and ANCC is held through November 2026.

Name

RMEI Medical Education

Legal name

RMEI Medical Education, LLC

Website

https://rmei.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

101–250 employees

Short description

RMEI Medical Education is a privately held, jointly accredited continuing medical education provider that designs and delivers free CE activities for physicians, pharmacists, nurses, and other healthcare professionals across ten specialty therapeutic areas, funded by pharmaceutical educational grants and featuring the AGA-endorsed IBD Clinical Decision Support Tool.

Ownership category

akta.pro rank

Product category

Continuing Medical Education

NAICS

Educational Support Services (611710), Colleges, Universities, and Professional Schools (6113)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industries

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Healthcare & Life Sciences (EDAAAPAA), Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)

Keywords

• Continuing medical education
• Medical education services
• Clinical decision support
• Healthcare professional training
• Accredited CE programs

Headquarters

HQ city

Voorhees

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Continuing Education Accreditation: RMEI provides accredited continuing education for healthcare professionals, certified for physicians, pharmacists, nurses, social workers, and other healthcare professionals. Revenue is generated through the accreditation process and educational grant funding from pharmaceutical companies.
2. Educational Grants: Supported by independent educational grants from pharmaceutical companies including Takeda Pharmaceuticals, Genentech, Insmed, CSL Behring, and others to develop and deliver CME activities.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

RMEI Medical Education provides jointly accredited continuing medical education (CME/CE) activities for healthcare professionals across ten specialty therapeutic areas, delivered through live events and on-demand web-based platforms using proprietary educational formats. Programming is funded by independent educational grants from pharmaceutical companies and is provided free of charge to clinicians. The company also develops clinical decision support tools, most notably the AGA-endorsed IBD Clinical Decision Support Tool (CDST), a free web-based predictive analytics application for biologic therapy selection.

Product overview

RMEI Medical Education operates as a jointly accredited continuing medical education (CME) provider offering a portfolio of educational products and services for healthcare professionals. The core offering includes web-based and live CE activities across ten specialty areas (Allergy & Immunology, Dermatology, Gastroenterology, Hematology/Oncology, Infectious Disease, Neuroscience, Ophthalmology, Psychiatry, Pulmonology, and Transplant). The flagship product is the IBD Clinical Decision Support Tool (CDST), a free web-based predictive analytics tool endorsed by the AGA that helps clinicians select optimal biologic therapies for IBD patients. Supporting the CE activities are thirteen proprietary educational formats including Clinical Convergence®, Clinical Consults®, Care Team Forum®, Clinical Journeys®, Clinical Transfers®, Clinical Exchanges®, Clinical Reflections®, Clinical Chronicles℠, Clinical Forum®, Clinical Olympics℠, and Clinical Sprints®. Additional offerings include Decision Support Aids/Patient Infographics, Educational Outcomes Posters, and Patient Education Resources developed through partnerships with non-profit organizations.

Differentiator

Problem solved

Functional benefit

Products and services

• RMEI CE Activities (Continuing Medical Education) Accredited web-based and live continuing medical education activities for physicians, pharmacists, nurses, social workers, and other healthcare professionals across Allergy & Immunology, Dermatology, Gastroenterology, Hematology/Oncology, Infectious Disease, Neuroscience, Ophthalmology, Psychiatry, Pulmonology, and Transplant. CE credits are issued upon completion of post-test and evaluation, and activities are provided free of charge.
• IBD Clinical Decision Support Tool (CDST) Free, web-based, interactive point-of-care tool accessible from any device that helps clinicians predict an IBD patient's response to biologic or targeted therapy before treatment initiation. Uses predictive modeling to provide differential predictions for endoscopic remission with vedolizumab, adalimumab, and tofacitinib based on disease extent, anti-TNF exposure, laboratory values, and surgical history. Endorsed by the AGA in 2021.
• Decision Support Aids / Patient Infographics Quick reference materials designed to help clinicians apply CE content to daily practice and patient care, available across multiple therapeutic areas as downloadable educational resources.
• Educational Outcomes Posters Published research posters presenting educational outcomes data from RMEI's CE programs, presented at major medical and continuing education conferences to demonstrate impact.
• Patient Education Resources Educational programs and resources developed for patients and caregivers in partnership with leading non-profit organizations including The Leukemia & Lymphoma Society, Crohn's & Colitis Foundation, The Lustgarten Foundation, and the Centers for Disease Control and Prevention.

Quantifiable outcome

• 243% overall improvement in correctness and confidence among clinicians using IBD CDST
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature7 records

Partnerships

Eleven partnerships are on record, tiered flagship, core, major and minor.

• American Gastroenterological Association (AGA)flagshipGTM or Marketing Partner · 17 February 2021AGA officially endorsed the IBD CDST in 2021, underlining the importance of the tool for clinicians choosing biologics for IBD patients. AGA has grown to more than 16,000 members involved in gastroenterology science, practice, and advancement.
• US IBD Health Outcomes ConsortiumcoreStrategic or Co-development Partner · 1 January 2019Network of leading IBD treatment centers across the United States led by Parambir Dulai, MD from Northwestern University. The Consortium provides data from pivotal Phase 3 clinical trials and real-world patient data used to build and validate the IBD CDST.
• ArcheMedXcoreTechnology or IntegrationArcheMedX is the learning technology company overseeing the technical build of the IBD CDST platform. They provide the Ready platform using behavioral science to improve how clinicians learn and retain information, leading to accelerated adoption of new clinical treatments and best practices.
• Partners for Advancing Clinical EducationcoreStrategic or Co-development PartnerJoint accreditation partner that provides continuing education activities for healthcare professionals. Partners is jointly accredited by ACCME, ACPE, and ANCC, and works with RMEI on activity development and delivery.
• Takeda Pharmaceuticals U.S.A., Inc.majorOthersPrimary supporter of educational grants for RMEI programming including CMV management activities and IBD CDST initiatives. Multiple activities are supported by Takeda educational grants.
• Genentech (Roche Group)majorOthersProvided independent educational grant for food allergy educational programming.
• InsmedmajorOthersProvided independent educational grant for NCFBE (non-cystic fibrosis bronchiectasis) educational activity.
• The Leukemia & Lymphoma SocietyminorStrategic or Co-development PartnerCollaborative partnership with non-profit organization serving patients and families dealing with blood cancers. RMEI works with leading non-profit organizations to provide unique opportunities for patient and caregiver education.
• Crohn's & Colitis FoundationminorStrategic or Co-development PartnerPartnership for inflammatory bowel disease patient education and resources. Collaborated on patient education opportunities.
• The Lustgarten FoundationminorStrategic or Co-development PartnerPartnership for pancreatic cancer patient education and support resources.
• Centers for Disease Control and Prevention (CDC)minorStrategic or Co-development PartnerGovernment agency partnership for patient education resources on conditions such as C. difficile infection and CMV.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Vindico Medical Education: Vindico Medical Education is an accredited provider of continuing medical education for physicians, pharmacists, and nurses, offering live and online activities funded by educational grants. It directly competes with RMEI in the pharma-funded specialty CME space.
• Global Education Group: Global Education Group is an accredited provider of interprofessional continuing education activities for healthcare professionals, with joint accreditation and a portfolio of live and online CE. It is a direct peer to RMEI in joint-accredited interprofessional CE.
• Haymarket Medical Education: Haymarket Medical Education is an accredited provider of CME/CE activities for healthcare professionals across multiple therapeutic areas, supported by educational grants from pharmaceutical companies. It is a closely comparable peer in scale and operating model to RMEI.
• Clinical Care Options: Clinical Care Options (CCO) is a global CME/CE provider focused on HIV, oncology, and other specialty therapeutic areas, combining live meetings, online activities, and decision-support tools. It is a direct peer to RMEI in pharma-funded specialty CME with proprietary educational platforms.
• Postgraduate Institute for Medicine (PIM): PIM is an accredited continuing education provider offering joint-accredited CME/CE activities across many therapeutic areas for multiple health professions. It directly competes with RMEI for accreditation-driven, pharma-funded programming.
• Pri-Med: Pri-Med is a major US CME provider combining live in-person and virtual meetings with online CE activities, primarily serving primary care clinicians. It directly competes with RMEI for clinician attention, pharma educational grants, and partnership with professional associations.
• Integrity Continuing Education: Integrity Continuing Education is an accredited provider of live and online CME/CE activities for physicians, pharmacists, and nurses, funded by educational grants. It competes directly with RMEI in specialty pharma-funded continuing education.
• CME Outfitters: CME Outfitters is an accredited continuing education provider offering live and online CME/CE activities across multiple therapeutic areas, funded by educational grants. It is a closely comparable peer in business model, scale, and therapeutic area breadth to RMEI.

Broad incumbents

• Medscape Education: Medscape Education (owned by WebMD/Internet Brands) is one of the largest online CME/CE providers globally, serving physicians and other healthcare professionals across virtually every therapeutic area. It is a direct functional peer to RMEI in continuing medical education delivery, with a much broader portfolio and reach.

Others

• ArcheMedX: ArcheMedX is the learning technology company that co-developed the IBD CDST platform with RMEI and the US IBD Health Outcomes Consortium. It is a technology partner and adjacent peer in delivering behavioral-science-based clinician learning platforms.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/RMEIMedEd
• YouTubeyoutube.com/user/rmeicom
• Facebookfacebook.com/RMEIfreecme
• LinkedInlinkedin.com/company/rmeimeded

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RMEI Medical Education